{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:49:51Z","timestamp":1784616591741,"version":"3.55.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Biomarkers can be used to assess the severity of spinal muscular atrophy (5q SMA; SMA). Despite their potential, the relationship between biomarkers and clinical outcomes in SMA remains underexplored. This study aimed to assess the association among biomarkers, phenotypes, and motor milestones in Chinese patients diagnosed with SMA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We collected retrospective clinical and follow-up data of disease-modifying therapy (DMT)-na\u00efve patients with SMA at our center from 2019 to 2021. Four biomarkers were included: survival motor neuron 2 (SMN2) copies, neuronal apoptosis inhibitory protein (NAIP) copies, full-length SMN2 (<jats:italic>fl<\/jats:italic>-SMN2), and F-actin bundling protein plastin 3 (PLS3) transcript levels. Data were analyzed and stratified according to SMA subtype.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 123 patients, 30 were diagnosed with Type 1 (24.3%), 56 with Type 2 (45.5%), and 37 with Type 3 (30.1%). The mortality rate for Type 1 was 50%, with median survival times of 2 and 8 months for types 1a and 1b, respectively. All four biomarkers were correlated with disease severity. Notably, <jats:italic>fl<\/jats:italic>-SMN2 transcript levels increased with SMN2 copies and were higher in Type 2b than those in Type 2a (<jats:italic>p<\/jats:italic> = 0.028). Motor milestone deterioration was correlated with SMN2 copies, NAIP copies, and <jats:italic>fl<\/jats:italic>-SMN2 levels, while PLS3 levels were correlated with standing and walking function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our findings suggest that SMN2 copies contribute to survival and that <jats:italic>fl<\/jats:italic>-SMN2 may serve as a valuable biomarker for phenotypic variability in SMA Type 2 subtypes. These insights can guide future research and clinical management of SMA.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1382410","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T14:26:22Z","timestamp":1725287182000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Association among biomarkers, phenotypes, and motor milestones in Chinese patients with 5q spinal muscular atrophy types 1\u20133"],"prefix":"10.3389","volume":"15","author":[{"given":"Shijia","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoti","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiushan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q\u2013linked spinal muscular atrophy \u2013 a literature review","volume":"12","author":"Verhaart","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e18975","DOI":"10.1097\/md.0000000000018975","article-title":"The prevalence of spinal muscular atrophy carrier in China","volume":"99","author":"Li","year":"2020","journal-title":"Medicine"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/jpm10030075","article-title":"The identification of novel biomarkers is required to improve adult SMA patient stratification, diagnosis and treatment","volume":"10","author":"Smeriglio","year":"2020","journal-title":"J Pers Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3390\/ijms21093297","article-title":"New and developing therapies in spinal muscular atrophy: from genotype to phenotype to treatment and where do we stand?","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fneur.2019.00898","article-title":"Biomarkers and the development of a personalized medicine approach in spinal muscular atrophy","volume":"10","author":"Kariyawasam","year":"2019","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00415-022-11326-1","article-title":"MRI correlates of motoneuron loss in SMA","volume":"270","author":"Sprenger-Sva\u010dina","year":"2022","journal-title":"J Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/jnnp-2016-314292","article-title":"Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0\u20134","volume":"88","author":"Wadman","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e1634","DOI":"10.1212\/wnl.0000000000009248","article-title":"Population-based analysis of survival in spinal muscular atrophy","volume":"94","author":"Wijngaarde","year":"2020","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nmd.2021.03.002","article-title":"Factors associated with delayed diagnosis of spinal muscular atrophy in China and changes in diagnostic delay","volume":"31","author":"Cao","year":"2021","journal-title":"Neuromuscul Disord"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s13023-021-02130-7","article-title":"National Rare Diseases Registry System (NRDRS): China\u2019s first nation-wide rare diseases demographic analyses","volume":"16","author":"Guo","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/0883073811420152","article-title":"The natural history of infant spinal muscular atrophy in China: a study of 237 patients","volume":"27","author":"Ge","year":"2011","journal-title":"J Child Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/0883073814553271","article-title":"Association of Copy Numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein gene with the natural history in a Chinese spinal muscular atrophy cohort","volume":"30","author":"Qu","year":"2014","journal-title":"J Child Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications","author":"Zerres","year":"1995","journal-title":"Arch Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/jhg.2013.111","article-title":"Correlation of PLS3 expression with disease severity in children with spinal muscular atrophy","volume":"59","author":"Cao","year":"2014","journal-title":"J Hum Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jmoldx.2016.05.004","article-title":"Mutation Spectrum of the survival of motor neuron 1 and functional analysis of variants in Chinese spinal muscular atrophy","volume":"18","author":"Qu","year":"2016","journal-title":"J Mol Diagn"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ejhg.2009.116","article-title":"SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR","volume":"18","author":"Tiziano","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/hmg\/ddab350","article-title":"Antisense oligonucleotides targeting the SMN2 promoter region enhance SMN2 expression in spinal muscular atrophy cell lines and mouse model","volume":"31","author":"Wang","year":"2022","journal-title":"Hum Mol Genet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1399-0004.2009.01200.x","article-title":"Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling","volume":"76","author":"Rudnik-Sch\u00f6neborn","year":"2009","journal-title":"Clin Genet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e548","DOI":"10.1542\/peds.2004-0668","article-title":"Spinal muscular atrophy: survival pattern and functional status","volume":"114","author":"Chung","year":"2004","journal-title":"Pediatrics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1038012","DOI":"10.3389\/fneur.2022.1038012","article-title":"Comprehensive profile and natural history of pediatric patients with spinal muscular atrophy: a large retrospective study from China","volume":"13","author":"Hu","year":"2022","journal-title":"Front Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/wnl.0000000000007742","article-title":"Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy","volume":"93","author":"Wijngaarde","year":"2019","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/acn3.283","article-title":"Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study","volume":"3","author":"Kolb","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"117727192110356","DOI":"10.1177\/11772719211035643","article-title":"Update on biomarkers in spinal muscular atrophy","volume":"16","author":"Pino","year":"2021","journal-title":"Biomark Insights"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/mus.21832","article-title":"Insights into genotype-phenotype correlations in spinal muscular atrophy: a retrospective study of 103 patients","volume":"43","author":"Petit","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/01.wco.0000093102.34793.13","article-title":"Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling","volume":"16","author":"Anderson","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s43042-019-0044-z","article-title":"Genetic pattern of SMN1, SMN2, and NAIP genes in prognosis of SMA patients","volume":"21","author":"Hassan","year":"2020","journal-title":"Egypt J Med Hum Genet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3988\/jcn.2017.13.1.27","article-title":"Genotype-phenotype correlation of SMN1 and NAIP deletions in Korean patients with spinal muscular atrophy","volume":"13","author":"Ahn","year":"2017","journal-title":"J Clin Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ejpn.2016.07.017","article-title":"Genotype\u2013phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina","volume":"20","author":"Medrano","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"ref32","first-page":"72","article-title":"The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease","volume":"60","author":"Burglen","year":"1997","journal-title":"Am J Hum Genet"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/1753","article-title":"Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics","volume":"20","author":"Scharf","year":"1998","journal-title":"Nat Genet"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.gene.2012.12.109","article-title":"Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy","volume":"518","author":"He","year":"2013","journal-title":"Gene"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12883-016-0651-y","article-title":"New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12891-015-0457-x","article-title":"Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls","volume":"16","author":"Fang","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e18809","DOI":"10.1097\/md.0000000000018809","article-title":"The analysis of the association between the copy numbers of survival motor neuron gene 2 and neuronal apoptosis inhibitory protein genes and the clinical phenotypes in 40 patients with spinal muscular atrophy","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e33572","DOI":"10.1371\/journal.pone.0033572","article-title":"Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study","volume":"7","author":"Crawford","year":"2012","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"9029","DOI":"10.3390\/ijms22169029","article-title":"The importance of digging into the genetics of SMN genes in the therapeutic scenario of spinal muscular atrophy","volume":"22","author":"Costa-Roger","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/jmg.2010.079004","article-title":"The c.859G>C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor","volume":"47","author":"Bernal","year":"2010","journal-title":"J Med Genet"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.nmd.2018.01.003","article-title":"Correlation between SMA type and SMN2 copy number revisited: an analysis of 625 unrelated Spanish patients and a compilation of 2834 reported cases","volume":"28","author":"Calucho","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1631\/jzus.B1500072","article-title":"Association between SMN2 methylation and disease severity in Chinese children with spinal muscular atrophy","volume":"17","author":"Cao","year":"2016","journal-title":"J Zhejiang Univ Sci B"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition","volume":"18","author":"Hauke","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1089\/gtmb.2010.0253","article-title":"Accuracy of marker analysis, quantitative real-time polymerase chain reaction, and multiple ligation-dependent probe amplification to determine SMN2 copy number in patients with spinal muscular atrophy","volume":"15","author":"Al\u00edas","year":"2011","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e0220211","DOI":"10.1371\/journal.pone.0220211","article-title":"The frequency of SMN gene variants lacking exon 7 and 8 is highly population dependent","volume":"14","author":"Vijzelaar","year":"2019","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1007\/s00018-021-03843-5","article-title":"Plastin 3 in health and disease: a matter of balance","volume":"78","author":"Wolff","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1055\/s-0042-1751302","article-title":"Investigation on the effects of modifying genes on the spinal muscular atrophy phenotype","volume":"9","author":"Zhuri","year":"2022","journal-title":"Global Medical Genetics"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"166063","DOI":"10.1016\/j.bbadis.2020.166063","article-title":"Spinal muscular atrophy: broad disease spectrum and sex-specific phenotypes","volume":"1867","author":"Singh","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e1241","DOI":"10.1212\/wnl.0000000000008166","article-title":"Long-term progression in type II spinal muscular atrophy: a retrospective observational study","volume":"93","author":"Mercuri","year":"2019","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.3389\/fneur.2024.1512459","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000}}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1382410\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T17:08:17Z","timestamp":1730135297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1382410\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":50,"alternative-id":["10.3389\/fneur.2024.1382410"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1382410","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fneur.2024.1512459","asserted-by":"object"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"article-number":"1382410"}}